A
Menu
March 29, 2007 article

Two randomized phase III clinical trials evaluating anti-inflammatory dose doxycycline (40-mg doxycycline, USP capsules) administered once daily for treatment of rosacea

Journal of the American Academy of Dermatology

DOI: 10.1016/j.jaad.2006.11.021 OpenAlex

Authors 0

  1. Author list not loaded yet.

Cited by 1 stored of 225

1 result

References 0